An Open Labelled Parallel Comparative Clinical Study to evaluate the efficacy of Krakashdaladi Kwath and Navaka Guggulu in the management of Medodushti with special reference to Dyslipidemia - nil

Institute For Ayurved Studies and Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.Patients willing to sign the consent form.2.Patients between the age group of 25-45 years of either gender.3.Patients having underweight, normal weight, overweight, and class I obesity according to BMI.4.Diagnosed & confirmed cases of Medodushti (Dyslipidemia) & Medoroga on the basis of criteria given by NCEP-ATPIII. (Borderline High category).

•a) Patient not fulfilling inclusion criteria.
•b) Patient not willing for clinical trial.
•c) Patient below 25yrs of age group and above 45yrs of age group.
•d) Patients having medical history of – CAD, CKD, AKD, Uncontrolled Diabetes Mellitus, Uncontrolled Hypertension.
•e) Patient on steroid therapy and oral contraceptive therapy.
•f) Pregnant women and lactating mothers.

发起方

Institute For Ayurved Studies and Research